Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Clin Neuropsychol. 2018 May 6;33(1):75–89. doi: 10.1080/13854046.2018.1465124

Table 3.

Descriptive statistics of medical comorbidities

Total Sample
[N (%)]
Low Needs
[N (%)]
Moderate Needs
[N (%)]
High Needs
[N (%)]
Refusal
[N (%)]
Neurological 133 (48%) 19 (48%) 15 (38%) 62 (50%) 37 (30%)
Cardiovascular 217 (78%) 26 (65%) 20 (74%) 97 (78%) 64 (52%)
Endocrine 102 (36%) 12 (30%) 15 (38%) 46 (37%) 29 (23%)
Gastrointestinal 49 (18%) 5 (13%) 7 (18%) 16 (13%) 21 (17%)
Infectious Disease/Autoimmune 68 (24%) 10 (25%) 6 (15%) 29 (23%) 23 (18%)
Musculoskeletal 76 (27%) 5 (13%) 6 (15%) 36 (29%) 29 (23%)
Pain 33 (12%) 4 (10%) 5 (13%) 11 (9%) 13 (10%)
Pulmonary 88 (31%) 10 (25%) 13 (33%) 37 (30%) 28 (22%)
Cancer 56 (20%) 9 (25%) 12 (31%) 23 (18%) 12 (10%)
Sensory-Perceptual 39 (14%) 8 (20%) 4 (10%) 19 (15%) 8 (6%)
Liver 17 (6%) 2 (5%) 6 (15%) 4 (3%) 5 (4%)
Cognition 66 (24%) 10 (25%) 10 (26%) 37 (30%) 9 (7%)
Psychiatric 126 (45%) 20 (50%) 18 (46%) 51 (41%) 37 (30%)
Substance Use 97 (35%) 13 (33%) 13 (33%) 49 (39%) 22 (18%)
Renal/Urogenital 123 (44%) 15 (38%) 19 (49%) 52 (42%) 24 (19%)

Note. Percentages rounded to nearest whole number